ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 162 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q1 2021. The put-call ratio across all filers is 0.87 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,140,271 | -61.1% | 44,629 | -56.3% | 0.00% | -66.7% |
Q2 2023 | $2,927,855 | -38.4% | 102,087 | -20.5% | 0.00% | -25.0% |
Q4 2021 | $4,750,000 | +3.8% | 128,363 | +34.0% | 0.00% | 0.0% |
Q3 2021 | $4,575,000 | -55.7% | 95,766 | -68.6% | 0.00% | -55.6% |
Q2 2021 | $10,324,000 | +212.7% | 305,090 | +281.7% | 0.01% | +200.0% |
Q1 2021 | $3,302,000 | +1100.7% | 79,938 | +1260.9% | 0.00% | – |
Q2 2020 | $275,000 | – | 5,874 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Green Alpha Advisors, LLC | 8,394 | $264,663 | 0.19% |
Global Wealth Strategies & Associates | 100 | $3,153 | 0.00% |